journal articles
CLASS-LEVEL AGGREGATION OBSCURES CLINICALLY RELEVANT HETEROGENEITY IN ANTI-AMYLOID ANTIBODY TRIALS: COMMENTS ON A COCHRANE REVIEW BY INDIVIDUAL MEMBERS OF THE EADC
Kristian Steen Frederiksen, Mercè Boada, Lutz Frölich, Milica Kramberger, Nikolaos Scarmeas, Everard Vijverberg, Pieter Jelle Visser, Gunhild Waldemar, Eric Westman, Henrik Zetterberg, Sebastiaan Engelborghs, Frank Jessen
CITATION:
Kristian Steen Frederiksen ; Mercè Boada ; Lutz Frölich ; Milica Kramberger ; Nikolaos Scarmeas ; Everard Vijverberg ; Pieter Jelle Visser ; Gunhild Waldemar ; Eric Westman ; Henrik Zetterberg ; Sebastiaan Engelborghs ; Frank Jessen (2025): Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2026.100598